Evidence map›Paper›PMID 33304940›Full record

ArticleEuropean journal of radiology open2020

Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences.

Kumar K Shashi, Rachna Madan, Mark M Hammer, Steven van Hedent, Suzanne C Byrne, Eric J Schmidlin, Harvey Mamon, Hiroto Hatabu, Peter C Enzinger, Victor H Gerbaudo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of radiology open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Special Issue: Chest Imaging 2021.European journal of radiology open · 2021
    Article
  4. Role of Positron Emission Tomography/Computed Tomography in Gastrointestinal Malignancies: A Brief Review and Pictorial Essay.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kumar K ShashiDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Rachna MadanDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Mark M HammerDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Steven van HedentDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Suzanne C ByrneDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Eric J SchmidlinDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Harvey MamonDepartment of Radiation Oncology, Brigham and Women's Hospital and Dana-Faber Cancer Center, and Harvard Medical School, Boston, MA, USA.
Hiroto HatabuDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Peter C EnzingerMedical Oncology, Brigham and Women's Hospital and Dana-Faber Cancer Center, and Harvard Medical School, Boston, MA, USA.
Victor H GerbaudoDepartment of Radiology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Brigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA multidisciplinary team approach to the management of esophageal cancer patients leads to better clinical decisions. PURPOSE: The contribution of CT, endoscopic and laparoscopic ultrasound to clinical staging and treatment selection by multidisciplinary tumor boards (MTB) in patients with esophageal cancer is well documented. However, there is a paucity of data addressing the role that FDG-PET/CT (PET/CT) plays to inform the clinical decision-making process at MTB conferences. The aim of this study was to assess the impact and contribution of PET/CT to clinical management decisions and to the plan of care for esophageal cancer patients at the MTB conferences held at our institution. MATERIALS AND

methodsThis IRB approved study included all the cases discussed in the esophageal MTB meetings over a year period. The information contributed by PET/CT to MTB decision making was grouped into four categories.

results79 patients (61 males and 18 females; median age, 61 years, range, 33-86) with esophageal cancer (53 adenocarcinomas and 26 squamous cell carcinomas) were included. The contribution of PET/CT-derived information was as follows:

conclusionThe study showed that PET/CT provided additional information and changed clinical management in 1 out of 3 (33%) esophageal cancer cases discussed at MTB conferences. These results support the inclusion whenever available, of FDG-PET/CT imaging information to augment and improve the patient management decision process in MTB conferences.

Indexed as

Esophageal cancerFDGNeoadjuvant therapyPET/CTRadiation therapyTumor board

Identifiers

PMID33304940
PMCPMC7711212
OpenAlexW3107240671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.